-
ABPI Website
-
ABPI UK Nations
- ABPI Scotland
ABPI Scotland
ABPI Scotland was established at the reconvening of the Scottish Parliament in 1999. The ABPI Scotland team works to represent the interests of our member companies to stakeholders here in Scotland.
We ensure that bodies such as the Scottish Government and NHS Scotland are kept informed about the issues affecting our sector and we also work closely with member companies to support their relations ensuring that they are supported in navigating the landscape of a devolved Scotland within the United Kingdom.
Fraser of Allander Institute Report
The pharmaceutical sector plays an important role in the Scottish economy. This report, by the Fraser of Allander Institute (FAI) at the University of Strathclyde, looks at the value of the sector.
What is the value of the pharmaceutical industry to Scotland?
The wider pharmaceutical sector itself employs 5,600 full-time equivalent (FTE) jobs and, once spill over effects are accounted for, generates £1.8bn of Gross Value Added in Scotland.
On its own, the manufacturing of pharmaceuticals employs around 4,000 people, with significant employment in rural areas.
The sector has complex supply chains and every pound of value created by the pharmaceutical sector, in turn, generates further value and jobs.
For every 10 jobs in the wider pharmaceutical industry a further 17 are supported in the wider economy.
ABPI Scotland publications
-
Cross Party Group (CPG) Annual report 2024
This is the third annual report of the Cross-Party Group on Life Sciences in the Scottish Parliament for the current session.
-
Cross Party Group (CPG) Annual report 2024
This is the third annual report of the Cross-Party Group on Life Sciences in the Scottish Parliament for the current session.
-
ABPI Scotland - A blueprint for health
There is a huge opportunity for Scotland to be a leader in data systems and genomic diagnostics, as well as adopting policies that support access to innovation for patients. The extent to which Scotland benefits – and perhaps leads – will ultimately be down to whether policymakers choose to adopt and fully harness the potential of research and innovation in healthcare.
-
Fraser of Allander Institute - The economic contribution of the Pharmaceuticals Sector in Scotland - February 2023
This report goes beyond economic impact assessment, highlighting the sector’s wider impact on the Scottish economy.
-
Scottish Cross Party Group Life Sciences Annual Report 2021-2022
The Group acts as a channel for communication and information between the Scottish Parliament and people within organisations working in the life sciences sector in Scotland across industry, academia, research, and manufacturing.
-
ABPI Scottish Cancer Recovery Roundtable
The COVID-19 pandemic has brought challenges to the way cancer treatments and clinical trials are delivered across Scotland and it is clear that collaboration will be required to ensure care returns to pre-pandemic levels.
-
ABPI Scotland Jargon Buster 2021
Creating an NHS ‘fit for the future’ is about embracing cutting edge technology so all patients in Scotland have access to world-class standards of care and disease prevention. We hope that this health jargon buster will help you translate the confusing array of acronyms used in the healthcare field.
-
ABPI Scotland 2021 Manifesto for Medicine
Our manifesto outlining a number of actions for the next Scottish Government to take that will improve the nation’s collective health and wealth.
-
The economic contribution of the pharmaceutical sector in Scotland
The pharmaceutical sector plays an important role in the Scottish economy. This report, by the Fraser of Allander Institute (FAI) at the University of Strathclyde, looks at the value of the sector.
-
The economic contribution of the pharmaceutical industry in Scotland
This analysis has been prepared by the Fraser of Allander Institute (FAI) at the University of Strathclyde. The technical analysis, methodology and writing of the results was undertaken independently by the FAI. It explores the value of the pharmaceutical industry in Scotland.
-
ABPI Scotland: Medicines for Scottish life
Health outcomes in Scotland are improving. Cancer survival, for instance – which is heavily dependent on oncology medicines – has improved by 18 per cent for men and 15 per cent for women between 1983 and 2007.
-
Contribution of pharma-related businesses to the Scottish economy
This is the third in a series of independent reports commissioned by ABPI Scotland with Ewen Peters’ Associates (EPA) which estimates the economic impact of “pharma-related businesses” in Scotland, both directly and more widely.
ABPI Scotland Staff
ABPI Scotland is led by Alison Culpan, ABPI Scotland Director, and Claire Headspeath, Operations Manager.
ABPI Scotland
The ABPI Scotland team work from home so please direct any post to the London office.
2nd Floor Goldings House,
Hay’s Galleria,
2 Hay’s Lane,
London, SE1 2HB
You can contact the Scotland team by phone on +44 (0) 131 523 0497.
Alternatively, you can email us via the Contact us form (select 'ABPI Scotland').
Last modified: 26 June 2024
Last reviewed: 26 June 2024